AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-59094_ITM" title="Facts and information about Itch, inflammation ointment. (Products).">Itch, inflammation ointment. (Products).</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Itch, inflammation ointment. (Products).
Cutivate (fluticasone propionate) ointment, 0.005%, is now indicated for the relief of inflammatory and pruritic manifestations of ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- Stiefel Laboratories received FDA approval for Olux-E (clobetasol propionate)...
- Magazine article from: Medical Marketing & Media March 1, 2007 700+ words
...Laboratories received FDA approval for Olux-E (clobetasol propionate) foam, for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 12 years of age or older. Steifel said Olux-E is will...
- Itch, inflammation ointment. (Products).(Brief Article)
- Magazine article from: Family Practice News June 1, 2002 700+ words
Cutivate (fluticasone propionate) ointment, 0.005%, is now indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adult patients. For more information, contact GlaxoSmithKline, 888-825-5249, www.gsk.com.
- Connetics evolves with Soriatane purchase; psoriasis market grows.
- Newspaper article from: Bioworld Financial Watch Osborne, Randall February 23, 2004 700+ words
...is for short-term treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses...might rub together). Luxiq is for inflammatory and pruritic manifestations of corticosteroid-responsive scalp dermatoses. Luxiq...
- PVSW, ARGA, OXIS, XHUA, EORIF, FVITF Have Also Been Removed From Naked Short...
- Press release article from: M2 Presswire June 19, 2008 700+ words
...Coraz Lotion for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as...Zytopic Cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as...
- NFBK, PVSW, ARGA, PAFRF, ABVG, PODM Have Also Been Added To Naked Short List...
- Press release article from: M2 Presswire June 11, 2008 700+ words
...Coraz Lotion for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as...Zytopic Cream for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as...
- Stiefel Laboratories Receives FDA Approval of Olux-E (Clobetasol Propionate)...
- Press release article from: Business Wire January 23, 2007 700+ words
...E is indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, also known...E is indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients...
- KV Pharmaceutical Company Reports Record Revenues for Fiscal 2005 Second...
- Press release article from: PR Newswire November 1, 2004 700+ words
...the brand Cutivate(R) marketed by GlaxoSmithKline, and is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adults. * Absorption of a 54% increase in R&D Expenses...
- FDA grants approval to market Olux for new indication.
- Newspaper article from: Immunotherapy Weekly January 22, 2003 700+ words
...intertriginous areas. Olux was previously approved for the short-term topical treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp including psoriasis. In late October...
- CONNETICS GETS FDA APPROVALTO EXPAND OLUX'S USE FOR PSORIASIS.
- Newspaper article from: Biotech Business February 1, 2003 700+ words
...intertriginous areas. OLUX was previously approved for the short-term topical treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp including psoriasis. In late October...
- Connetics Receives FDA Approval to Market OLUX(R) for Psoriasis.
- Press release article from: PR Newswire December 23, 2002 700+ words
...intertriginous areas. OLUX was previously approved for the short-term topical treatment of the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp including psoriasis. In late October...
Source: HighBeam Research, Itch, inflammation ointment. (Products).